Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis
Guillemette Laval(Université Grenoble Alpes), C. Arvieux(Université Grenoble Alpes), Blandine Marcelin-Benazech(Hospices Civils de Lyon), Éric François(Centre Antoine Lacassagne), Christine Rebischung, Frédéric Guirimand, L. Chauvenet(Assistance Publique – Hôpitaux de Paris), Éric Terrebonne(Hôpital Cardiologique du Haut-Lévêque), Aurélie Durand(Centre National de la Recherche Scientifique), Martine Gabolde(Hôpital Paul-Brousse), Vincent Servois(Université Paris Sciences et Lettres), Laure Copel(Institut Curie), Pascale Mariani(Université Paris Sciences et Lettres)
Cited by 139
Related Papers
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
|Journal of Clinical Oncology|2012|431
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|JAMA Oncology|2022|322